RxDoctor Payments Data

Jad Husseini, MD

Diagnostic Radiology · Boston, MANPI 1750656864

Payments from drug & device makers

$93,919in general payments, 2019–2025

Across 50 payments — averaging $1878.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB Biosciences Inc.$34K
  • Sanofi US Services Inc.$18K
  • GE HealthCare$13K
  • AbbVie$12K
  • Bioverativ Therapeutics Inc.$11K
  • Boehringer Ingelheim Italia S.p.a.$4K
  • plus $2K from 2 others

What the payments were for

  • Consulting fees$28,20087%
  • Speaking & faculty fees$4,38013%
  • Food & beverage$140%

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB Biosciences Inc.3$34,140
Sanofi US Services Inc.11$17,600
GE HealthCare1$13,140
AbbVie14$12,445
Bioverativ Therapeutics Inc.9$10,600
Boehringer Ingelheim Italia S.p.a.10$4,380
Astrazeneca UK Limited1$1,600
Teleflex LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$93,919 in reported general payments places this provider in the 90th percentile of 1,206 diagnostic radiology providers in Massachusetts.

See all diagnostic radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$107,925
Medicare patients
2,993
Services billed
4,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →